| Term 
 
        | What is the major cause of COPD? |  | Definition 
 
        | Cigarette smoke - not the only cause **Noxious stimuli to the lungs
 |  | 
        |  | 
        
        | Term 
 
        | What is a major difference between COPD and asthma? |  | Definition 
 
        | COPD is not reversible! - productive cough
 - No allergies
 - Coughing throughout the day
 - Not present in youth
 - Most prevalent in white women
 |  | 
        |  | 
        
        | Term 
 
        | What 5 components define COPD? |  | Definition 
 
        | - Preventable - Treatable
 - Airflow limitation
 - Chronic inflammation
 - Progressive
 |  | 
        |  | 
        
        | Term 
 
        | What are the old components of COPD? |  | Definition 
 
        | - Emphysema - destruction of alveoli - Chronic bronchitis - Primary productive cough
 |  | 
        |  | 
        
        | Term 
 
        | What genetic factor can cause COPD? |  | Definition 
 
        | alpha-1 antitrypsin deficiency. Missing elastic factor - remodeling occurs at all times |  | 
        |  | 
        
        | Term 
 
        | What is the main mechanisms of COPD? |  | Definition 
 
        | - Small airway fibrosis leads to air trapping and airway limitation that is measurable by spirometry - Chronic inflammation due to NEUTROPHILS, CD8 cells, and macrophages
 - Oxidative stress
 - Proteases break down elastin - irreversible
 |  | 
        |  | 
        
        | Term 
 
        | What cells are involved in asthma pathophysiology? |  | Definition 
 
        | Eosinophils, CD4 cells, and mast cells |  | 
        |  | 
        
        | Term 
 
        | What kind of acid/base disorder is present in COPD? |  | Definition 
 
        | Respiratory acidosis due to decline in respiration. ** Low FEV1 and gas exchange
 |  | 
        |  | 
        
        | Term 
 
        | How does mucous production affect COPD? |  | Definition 
 
        | Not in all patients - increased goblet cells and stimulation by EGFR --> incr mucous production |  | 
        |  | 
        
        | Term 
 
        | When does pulmonary hypertension occur? |  | Definition 
 
        | In late COPD Vasoconstriction of pulmonary arteries, SM hyperplasia, and loss of capillary bed --> can lead to right ventricle heart failure - swelling of the hands and feet, JVD
 |  | 
        |  | 
        
        | Term 
 
        | What do COPD exacerbations look like? |  | Definition 
 
        | - Increased neutrophils - Increased mediators
 - Increased air trapping
 **Increased dyspnea and hypoxemia
 |  | 
        |  | 
        
        | Term 
 
        | What are the signs and symptoms of COPD? |  | Definition 
 
        | - DYSPNEA - the cardinal symptom - Chronic cough - can be productive
 - Chronic sputum production
 - wheeze, chest tightness
 |  | 
        |  | 
        
        | Term 
 
        | What comorbidities are seen with COPD? |  | Definition 
 
        | - Weight loss, Skeletal muscle dysfunction - CV, metabolic, depression, lung cancer
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Questionnaires - mMRC of 2+ indicates significant symptoms Spirometry - FEV1/FVC ratio < 0.7
 Gold grade
 |  | 
        |  | 
        
        | Term 
 
        | How are COPD patients classified into GOLD grade based on FEV1? |  | Definition 
 
        | - Stage 1/mild - FEV1>= 80% - Stage 2/moderate - FEV between 50 and 80
 - Stage 3/Severe - FEV between 30 and 50
 - Stage 4/Very severe - FEV less than 30, or <50 w/ chronic respiratory failure
 |  | 
        |  | 
        
        | Term 
 
        | How is COPD exacerbation risk assessed? |  | Definition 
 
        | Square chart: Left side - mMRC 0-1 or CAT <10, patient is Grade A or C. Patient moves to grade C w/ 3-4 exacerbations
 - Right side - mMRC >= 2, CAT >= 10. Patient is grade B (0,1 exacerbation) or grade D (2+ exacerbations)
 |  | 
        |  | 
        
        | Term 
 
        | What are physical exam findings associated w/ COPD? |  | Definition 
 
        | - Cyanosis - Barrel chest
 - Increased RR
 - Pursed-lip breathing
 - use of accessory muscles
 - Lower extremity edema
 |  | 
        |  | 
        
        | Term 
 
        | What is the best non-pharmacologic Tx for COPD? |  | Definition 
 
        | STOP SMOKING! Prevents airflow limitation and improves mortality. |  | 
        |  | 
        
        | Term 
 
        | How is pack year history calculated? |  | Definition 
 
        | Pack year history = #of packs/day * # of years smoked |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | - NO medications modify long term lung fxn decline - NO medications improve mortality
 |  | 
        |  | 
        
        | Term 
 
        | What bronchodilators are used for COPD? |  | Definition 
 
        | - Beta agonists - SABA or LABA - Anticholinergics - Tiotropium or Ipratropium
 - Methylxanthines - Theophylline
 |  | 
        |  | 
        
        | Term 
 
        | How do bronchodilators work on COPD? |  | Definition 
 
        | - Decrease hyperinflation to improve symptoms and exercise tolerance - Reduction in exacerbations
 - Toxicity is dose dependent
 |  | 
        |  | 
        
        | Term 
 
        | How do B2 agonists work for COPD? |  | Definition 
 
        | - Increased cAMP --> bronchodilation - Asthma > COPD
 - Use proper inhaler technique
 - AE: tachycardia, tremor, hypokalemia
 |  | 
        |  | 
        
        | Term 
 
        | What beta agonists are available for COPD Tx? |  | Definition 
 
        | SABAs: - Albuterol/Ventolin
 - Levalbuterol/Xopenex
 - Pirbuterol/Maxair
 LABAs:
 - Salmeterol/Serevent
 - Formoterol/Foradil and perforomist
 - Arformoterol/Brovana
 |  | 
        |  | 
        
        | Term 
 
        | What medications is an ULTRA-long action beta2 agonist? |  | Definition 
 
        | Indacaterol/Arcapta Once daily - not for asthma use
 |  | 
        |  | 
        
        | Term 
 
        | How do anticholinergics work for COPD? |  | Definition 
 
        | Inhibition of Ach at muscarinic receptors --> inhibit bronchoconstriction. Lasts longer than beta agonists AE: DRY MOUTH, bitter, blurry vision, urinary retention
 |  | 
        |  | 
        
        | Term 
 
        | What anticholinergics are available for COPD? |  | Definition 
 
        | Short: - Ipratropium/Atrovent - do not use w/ peanut allergy!
 Long:
 - Tiotropium/Spiriva
 - Aclidinium/Tudorza
 **Tudorza inhaler - push down button, green = ready to use. Inhale, goes from green to red
 |  | 
        |  | 
        
        | Term 
 
        | What is the MoA of methylxanthines in COPD? |  | Definition 
 
        | non-selective PDE inhibitor --> increases cAMP --> bronchodilation **Inhaled agents are preferred. AE: tremor, arrhythmia, seizure, HA, GI
 |  | 
        |  | 
        
        | Term 
 
        | How do glucocorticoids work in COPD? |  | Definition 
 
        | - Decrease mucous, inhibit release of enzymes from leukocytes, inhibit PGs - Asthma > COPD
 - For patients with FEV < 60%
 |  | 
        |  | 
        
        | Term 
 
        | What drug is a PDE4 inhibitor for COPD? |  | Definition 
 
        | Roflumilast/Daliresp Increases cAMP by inhibiting PDE4, reduces inflammation. Do not dose w/ theophylline due to CYP induction
 AE: Nausea, diarrhea, weight loss
 |  | 
        |  | 
        
        | Term 
 
        | What vaccinations should a COPD patient get? |  | Definition 
 
        | - Flu shot - Pneumonia vaccine
 |  | 
        |  | 
        
        | Term 
 
        | How are Group A COPD patients treated? |  | Definition 
 
        | short acting agents prn - Albuterol or ipratropium |  | 
        |  | 
        
        | Term 
 
        | How are Group B COPD patients treated? |  | Definition 
 
        | - Long acting agents are FIRST LINE: LABAs - Salmeterol, formoterol, arformoterol
 Long acting cholinergics: Tiotropium, aclidinium
 |  | 
        |  | 
        
        | Term 
 
        | How are Group C COPD patients treated? |  | Definition 
 
        | Combo of ICS + LABA OR long acting cholinergics are FIRST LINE: - Advair - fluticasone + salmeterol
 - Spiriva
 |  | 
        |  | 
        
        | Term 
 
        | How are Group D COPD patients treated? |  | Definition 
 
        | Same as group C: Combo of ICS + LABA OR long acting cholinergics are FIRST LINE: - Advair - fluticasone + salmeterol
 - Spiriva
 **Can use triple therapy - Advair + Spiriva
 |  | 
        |  | 
        
        | Term 
 
        | What is non-pharmacologic Tx for COPD? |  | Definition 
 
        | - Pulmonary rehab that focuses on exercise training, nutrition, and education - O2 in stage 4. PaO2 cut off is <55
 |  | 
        |  | 
        
        | Term 
 
        | What studies exist about COPD meds? |  | Definition 
 
        | - UPLIFT - Spiriva decreases exacerbations - POET-COPD - Tiotropium > Salmeterol
 - TORCH - Advair > components or placebo
 |  | 
        |  | 
        
        | Term 
 
        | What is the most common risk factor for an acute COPD exacerbation? |  | Definition 
 
        | upper respiratory tract infection |  | 
        |  | 
        
        | Term 
 
        | How are COPD exacerbations classified? |  | Definition 
 
        | Accessory muscle use Chest wall movement
 Cyanosis
 Edema
 Hemodynamic instability
 Right sided HF
 Reduced alertness
 |  | 
        |  | 
        
        | Term 
 
        | How are systemic glucocorticoids dosed for an acute COPD exacerbation? |  | Definition 
 
        | 30-40 mg of prednisolone for 1-2 weeks |  | 
        |  | 
        
        | Term 
 
        | When should antibiotics be used for a COPD inpatient? |  | Definition 
 
        | Increase in 2-3 of: Dyspnea
 Cough
 Sputum production
 OR Mechanical ventilation
 |  | 
        |  | 
        
        | Term 
 
        | What comorbidities are seen with COPD? |  | Definition 
 
        | - CV - HF, afib - Osteoporosis - associated w/ emphysema, avoid triamcinolone
 - Depression/Anxiety - treat per usual
 - Metabolic syndrome/Diabetes
 |  | 
        |  |